Tag: Brock Dahl
Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
English
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
IHCF vice president SongYi Son discusses the merits and possible obstacles for doing business in South Korea
Follow us on LinkedIn